P., Van de Rest, O., Witkamp, R
Visceral fat reduction typically becomes measurable between 26 months, with maximal effects achieved at 6068 weeks
Findings were organized thematically according to 1) type of intervention (pharmacological vs nutraceutical) and 2) targeted clinical complication, such as oxidative stress, pruritus, cardiovascular manifestations, metabolic disturbances, and neurological symptoms
PubMed Kaufman G
For the estimated 25 to 35 percent of prospective GLP-1 patients who cite needle aversion as a primary barrier to starting treatment this format is clinically meaningful
Find articles by Lorenzen-Schmidt, I